Every 10-Q that Eos Energy Enterprises, Inc. (EOSE) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow EOSE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full EOSE filings page.
Eos Energy Enterprises, Inc. reported Q2 and first-half 2026 results with rapid top-line growth but continued operating losses. Total revenue was 68,775 and 125,738 (both in thousands of dollars) for Q2 and the first half, up from 15,236 and 25,693 a year earlier, including 55,034 of related-party product revenue.
Cost of goods sold of 117,576 and 218,966 (in thousands) exceeded revenue, resulting in gross losses of 48,801 and 93,228 and operating losses of 83,811 and 163,123. Two customers accounted for about 97.7% of Q2 revenue. The company recognized 22,798 of production tax credits in the first half and held 33,826 of related grant receivables.
Despite negative operating results, first-half net income attributable to shareholders was 233,173 (in thousands), reflecting non-cash gains including 146,140 on warrants, 95,488 on derivatives, 216,684 on related-party derivatives and a 648,320 remeasurement of related-party preferred stock. At June 30, 2026, cash, cash equivalents and restricted cash totaled 364,070, first-half operating cash outflow was 191,753, total debt principal was 948,284 and shareholders’ deficit was 1,030,784 (all in thousands).
Eos Energy Enterprises (EOSE) filed its Q3 2025 10‑Q, showing fast-growing sales alongside heavy losses and sizable non-cash fair value impacts. Revenue reached $30.5 million for the quarter, up from $0.9 million a year ago, but cost of goods sold of $64.4 million led to a gross loss. Operating loss was $61.2 million. After large changes in the fair value of warrants and related derivatives and preferred stock remeasurement, net loss attributable to common shareholders was $1.33 billion for Q3.
The balance sheet reflects expansion and financing activity: cash and cash equivalents were $58.7 million and restricted cash $36.9 million as of September 30, 2025. The company closed a public offering of 21,562,500 shares at $4.00 for net proceeds of $81.1 million on June 2, 2025, issued $250 million of 6.75% convertible notes due 2030, and drew $90.9 million from Tranche 1 of its DOE Loan Facility (up to $303.5 million across tranches). The Cerberus delayed draw term loan was fully funded, and its interest rate was reduced to 7% under amendments.
Management disclosed substantial doubt about the company’s ability to continue as a going concern, despite covenant compliance on minimum liquidity and deferral of revenue/EBITDA covenants to March 31, 2027.